213 filings
Page 4 of 11
8-K
fuqs8mzo
23 Jul 18
Departure of Directors or Certain Officers
12:00am
8-K
xzthvesmkkjes5obs0
8 Jun 18
Departure of Directors or Certain Officers
5:00pm
8-K
4pyxpb3
4 May 18
First Quarter 2018 Financial Results
7:43am
8-K
e0h49zihjj3aschf
27 Feb 18
Fourth Quarter and Full Year 2017 Financial Results
12:00am
8-K
ylpuxma683te dl
7 Nov 17
Third Quarter 2017 Financial Results
12:00am
8-K
vnb9yfeq2b1swhmxk1t
8 Aug 17
Second Quarter 2017 Financial Results
12:00am
8-K
0obfqxf
15 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
a4gt6o2q
9 May 17
First Quarter 2017 Financial Results
12:00am
8-K
xfk6y
31 Mar 17
Departure of Directors or Certain Officers
12:00am
8-K
7h00t5tg
28 Feb 17
NUPLAZID® Net Product Sales Grew to $12.0 Million in Fourth Quarter 2016
12:00am
8-K
9bdimhu8
20 Dec 16
ACADIA Pharmaceuticals Announces Positive Top-Line Results From Phase II Study of Pimavanserin for Alzheimer’s Disease Psychosis
12:00am
8-K
de2ceq 5l
16 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
r5bjozhha0 8n3ns0fhs
7 Nov 16
Third Quarter 2016 Financial Results
12:00am
8-K
ywf2hx 0p6tjm
24 Aug 16
Departure of Directors or Certain Officers
12:00am
8-K
8p43 ov87bw7rts4
10 Aug 16
Acadia Pharmaceuticals Announces Proposed Public Offering of Common Stock
12:00am
8-K
wcrnaavi59fyah ucbl
4 Aug 16
Second Quarter 2016 Financial Results
12:00am
8-K
tv69s4 ygow9fe
10 Jun 16
Departure of Directors or Certain Officers
12:00am
8-K
yge4a
5 May 16
First Quarter 2016 Financial Results
12:00am
8-K
dmp et81fty78flmn
3 May 16
The First Drug Approved for the Treatment of Hallucinations and Delusions Associated
12:00am
8-K
g4rt4xto1s4spd1b 8a
18 Mar 16
Departure of Directors or Certain Officers
12:00am